NewsBenzingaViridian Therapeutics、第3四半期EPSは(0.81ドル)で予想(1.00ドル)を上回る 売上高2万5,752ドルは予想508万4,000ドルと比較できない可能性 Viridian Therapeutics、第3四半期EPSは(0.81ドル)で予想(1.00ドル)を上回る 売上高2万5,752ドルは予想508万4,000ドルと比較できない可能性 Benzinga 2026.11.04 12:04 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3